alphaveAARTIDRUGS₹437.00

Aarti Drugs Ltd.

₹ CrorePeersALIVUS AARTIPHARM ADVENZYMES AGARWALEYE AKUMS APLLTD CORONA HCGMcap ₹3,988 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	808.2	856.3	1,068.3	1,068.3
+ Capital Work-in-Progress	225.2	330.2	213.8	213.8
+ Other Intangibles	1.2	7.2	16.4	16.4
+ Intangibles under Development	35.7	—	—	—
+ Non-current Investments	20.0	22.4	27.3	27.3
+ Other Non-current Financial Assets	—	20.3	—	—
Non-current Financial Assets	20.0	42.7	27.3	27.3
+ Other Non-current Assets	21.5	—	21.7	21.7
Total Non-current Assets	1,111.6	1,236.3	1,347.5	1,347.5
Current Assets
+ Inventories	485.9	472.9	490.8	490.8
+ Trade Receivables	704.6	751.2	829.9	829.9
+ Cash & Cash Equivalents	6.7	4.6	7.3	7.3
+ Other Bank Balances	2.7	3.0	1.5	1.5
+ Short-term Loans	0.2	0.8	0.7	0.7
+ Other Current Financial Assets	11.3	15.1	15.5	15.5
Current Financial Assets	725.6	774.6	854.9	854.9
+ Other Current Assets	109.3	80.9	122.1	122.1
Total Current Assets	1,320.7	1,338.4	1,467.8	1,467.8
Total Assets	2,432.4	2,574.7	2,815.3	2,815.3
Equity
+ Equity Share Capital	91.9	91.3	91.3	91.3
+ Other Equity / Reserves	1,189.6	1,277.7	1,457.6	1,457.6
Equity — Owners of Parent	1,281.6	1,369.0	1,548.9	1,548.9
+ Minority Interest	0.4	0.3	0.4	0.4
Total Equity	1,282.0	1,369.3	1,549.2	1,549.2
Liabilities
+ Borrowings — Non-current	275.3	284.0	256.9	256.9
+ Other Non-current Financial Liab	1.1	1.8	1.1	1.1
Non-current Financial Liabilities	276.4	285.8	258.0	258.0
+ Provisions — Non-current	2.7	4.3	4.6	4.6
+ Deferred Tax Liabilities	75.7	78.2	81.3	81.3
Non-current Liabilities	354.9	368.4	343.8	343.8
+ Borrowings — Current	287.1	328.2	318.0	318.0
+ Trade Payables	425.5	416.1	477.9	477.9
+ Other Current Financial Liab	27.3	21.4	23.8	23.8
Current Financial Liabilities	739.9	765.8	819.6	819.6
+ Provisions — Current	3.0	4.3	8.1	8.1
+ Current Tax Liabilities	1.2	0.0	7.2	7.2
+ Other Current Liabilities	51.6	66.9	87.4	87.4
Current Liabilities	795.5	837.0	922.3	922.3
Total Liabilities	1,150.4	1,205.3	1,266.0	1,266.0
Total Equity & Liabilities	2,432.4	2,574.7	2,815.3	2,815.3
Assets — additional as-filed lines
+ Current Tax Assets	—	10.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	11.8	24.1	24.1
+ Dues to Other Creditors — Current	—	404.3	453.8	453.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.